57 related articles for article (PubMed ID: 16322235)
1. Platelet-derived growth factor-induced p42/44 mitogen-activated protein kinase activation and cellular growth is mediated by reactive oxygen species in the absence of TSC2/tuberin.
Finlay GA; Thannickal VJ; Fanburg BL; Kwiatkowski DJ
Cancer Res; 2005 Dec; 65(23):10881-90. PubMed ID: 16322235
[TBL] [Abstract][Full Text] [Related]
2. Conditional and domain-specific inactivation of the Tsc2 gene in neural progenitor cells.
Fu C; Ess KC
Genesis; 2013 Apr; 51(4):284-92. PubMed ID: 23359422
[TBL] [Abstract][Full Text] [Related]
3. Regulation of PI 3-K, PTEN, p53, and mTOR in Malignant and Benign Tumors Deficient in Tuberin.
Habib SL; Yadav A; Mahimainathan L; Valente AJ
Genes Cancer; 2011 Nov; 2(11):1051-60. PubMed ID: 22737271
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy for tuberous sclerosis complex type 2 in a mouse model by delivery of AAV9 encoding a condensed form of tuberin.
Cheah PS; Prabhakar S; Yellen D; Beauchamp RL; Zhang X; Kasamatsu S; Bronson RT; Thiele EA; Kwiatkowski DJ; Stemmer-Rachamimov A; György B; Ling KH; Kaneki M; Tannous BA; Ramesh V; Maguire CA; Breakefield XO
Sci Adv; 2021 Jan; 7(2):. PubMed ID: 33523984
[TBL] [Abstract][Full Text] [Related]
5. Dynamic Akt/mTOR Signaling in Children with Autism Spectrum Disorder.
Onore C; Yang H; Van de Water J; Ashwood P
Front Pediatr; 2017; 5():43. PubMed ID: 28361047
[TBL] [Abstract][Full Text] [Related]
6. Histamine signaling and metabolism identify potential biomarkers and therapies for lymphangioleiomyomatosis.
Herranz C; Mateo F; Baiges A; Ruiz de Garibay G; Junza A; Johnson SR; Miller S; García N; Capellades J; Gómez A; Vidal A; Palomero L; Espín R; Extremera AI; Blommaert E; Revilla-López E; Saez B; Gómez-Ollés S; Ancochea J; Valenzuela C; Alonso T; Ussetti P; Laporta R; Xaubet A; Rodríguez-Portal JA; Montes-Worboys A; Machahua C; Bordas J; Menendez JA; Cruzado JM; Guiteras R; Bontoux C; La Motta C; Noguera-Castells A; Mancino M; Lastra E; Rigo-Bonnin R; Perales JC; Viñals F; Lahiguera A; Zhang X; Cuadras D; van Moorsel CHM; van der Vis JJ; Quanjel MJR; Filippakis H; Hakem R; Gorrini C; Ferrer M; Ugun-Klusek A; Billett E; Radzikowska E; Casanova Á; Molina-Molina M; Roman A; Yanes O; Pujana MA
EMBO Mol Med; 2021 Sep; 13(9):e13929. PubMed ID: 34378323
[TBL] [Abstract][Full Text] [Related]
7. Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion.
Zarei M; Du H; Nassar AH; Yan RE; Giannikou K; Johnson SH; Lam HC; Henske EP; Wang Y; Zhang T; Asara J; Kwiatkowski DJ
J Exp Med; 2019 Nov; 216(11):2635-2652. PubMed ID: 31506280
[TBL] [Abstract][Full Text] [Related]
8. Proapoptotic protein Bim attenuates estrogen-enhanced survival in lymphangioleiomyomatosis.
Li C; Li N; Liu X; Zhang EY; Sun Y; Masuda K; Li J; Sun J; Morrison T; Li X; Chen Y; Wang J; Karim NA; Zhang Y; Blenis J; Reginato MJ; Henske EP; Yu JJ
JCI Insight; 2016 Nov; 1(19):e86629. PubMed ID: 27882343
[TBL] [Abstract][Full Text] [Related]
9. mTORC1-Driven Tumor Cells Are Highly Sensitive to Therapeutic Targeting by Antagonists of Oxidative Stress.
Li J; Shin S; Sun Y; Yoon SO; Li C; Zhang E; Yu J; Zhang J; Blenis J
Cancer Res; 2016 Aug; 76(16):4816-27. PubMed ID: 27197195
[TBL] [Abstract][Full Text] [Related]
10. High-throughput drug screen identifies chelerythrine as a selective inducer of death in a TSC2-null setting.
Medvetz D; Sun Y; Li C; Khabibullin D; Balan M; Parkhitko A; Priolo C; Asara JM; Pal S; Yu J; Henske EP
Mol Cancer Res; 2015 Jan; 13(1):50-62. PubMed ID: 25185584
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin-resistant poly (ADP-ribose) polymerase-1 overexpression is a potential therapeutic target in lymphangioleiomyomatosis.
Sun Y; Gallacchi D; Zhang EY; Reynolds SB; Robinson L; Malinowska IA; Chiou TT; Pereira AM; Li C; Kwiatkowski DJ; Lee PS; Yu JJ
Am J Respir Cell Mol Biol; 2014 Dec; 51(6):738-49. PubMed ID: 24874429
[TBL] [Abstract][Full Text] [Related]
12. Autophagy-dependent metabolic reprogramming sensitizes TSC2-deficient cells to the antimetabolite 6-aminonicotinamide.
Parkhitko AA; Priolo C; Coloff JL; Yun J; Wu JJ; Mizumura K; Xu W; Malinowska IA; Yu J; Kwiatkowski DJ; Locasale JW; Asara JM; Choi AM; Finkel T; Henske EP
Mol Cancer Res; 2014 Jan; 12(1):48-57. PubMed ID: 24296756
[TBL] [Abstract][Full Text] [Related]
13. Cooperative benefit for the combination of rapamycin and imatinib in tuberous sclerosis complex neoplasia.
Govindarajan B; Willoughby L; Band H; Curatolo AS; Veledar E; Chen S; Bonner MY; Abel MG; Moses MA; Arbiser JL
Vasc Cell; 2012 Jul; 4(1):11. PubMed ID: 22765013
[TBL] [Abstract][Full Text] [Related]
14. Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex.
Goto J; Talos DM; Klein P; Qin W; Chekaluk YI; Anderl S; Malinowska IA; Di Nardo A; Bronson RT; Chan JA; Vinters HV; Kernie SG; Jensen FE; Sahin M; Kwiatkowski DJ
Proc Natl Acad Sci U S A; 2011 Nov; 108(45):E1070-9. PubMed ID: 22025691
[TBL] [Abstract][Full Text] [Related]
15. PYK2 signaling is required for PDGF-dependent vascular smooth muscle cell proliferation.
Perez J; Torres RA; Rocic P; Cismowski MJ; Weber DS; Darley-Usmar VM; Lucchesi PA
Am J Physiol Cell Physiol; 2011 Jul; 301(1):C242-51. PubMed ID: 21451101
[TBL] [Abstract][Full Text] [Related]
16. Effects of prolactin on TSC2-null Eker rat cells and in pulmonary lymphangioleiomyomatosis.
Terasaki Y; Yahiro K; Pacheco-Rodriguez G; Steagall WK; Stylianou MP; Evans JF; Walker AM; Moss J
Am J Respir Crit Care Med; 2010 Aug; 182(4):531-9. PubMed ID: 20413627
[TBL] [Abstract][Full Text] [Related]
17. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS.
Alexander A; Cai SL; Kim J; Nanez A; Sahin M; MacLean KH; Inoki K; Guan KL; Shen J; Person MD; Kusewitt D; Mills GB; Kastan MB; Walker CL
Proc Natl Acad Sci U S A; 2010 Mar; 107(9):4153-8. PubMed ID: 20160076
[TBL] [Abstract][Full Text] [Related]
18. Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.
Di Nardo A; Kramvis I; Cho N; Sadowski A; Meikle L; Kwiatkowski DJ; Sahin M
J Neurosci; 2009 May; 29(18):5926-37. PubMed ID: 19420259
[TBL] [Abstract][Full Text] [Related]
19. AMP-activated protein kinase signaling results in cytoplasmic sequestration of p27.
Short JD; Houston KD; Dere R; Cai SL; Kim J; Johnson CL; Broaddus RR; Shen J; Miyamoto S; Tamanoi F; Kwiatkowski D; Mills GB; Walker CL
Cancer Res; 2008 Aug; 68(16):6496-506. PubMed ID: 18701472
[TBL] [Abstract][Full Text] [Related]
20. Melatonin represses oxidative stress-induced activation of the MAP kinase and mTOR signaling pathways in H4IIE hepatoma cells through inhibition of Ras.
Kimball SR; Abbas A; Jefferson LS
J Pineal Res; 2008 May; 44(4):379-86. PubMed ID: 18410586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
